Intravesical prostatic protrusion predicts clinical progression of benign prostatic hyperplasia

ZHANG Hao,SITU Jie,ZHANG Yan,GAO Xin,LU Min-hua
DOI: https://doi.org/10.3877/cma.j.issn.1674-3253.2012.04.013
2012-01-01
Abstract:Objectives To assess intravesical prostatic protrusion(IPP) as a novel predictor of clinical progression in patients with benign prostatic hyperplasia(BPH).Methods All patients attending the outpatient clinic at our institution who were being treated for lower urinary tract symptoms(LUTS) secondary to BPH between 2002 and 2009 were recruited into the study.IPP was classified into Grade 1,2 or 3.Age,prostate volume,serum prostate-specific antigen(PSA),International Prostate Symptom Score(IPSS) scores,uroflowmetry parameters,post-void residual urine volume(PVR) were also collected.Patients were stratified to different treatment options including watchful waiting,alpha blockers or 5-alpha reductase inhibitors.Those who developed a deterioration of at least 4 points in IPSS score,Qmax descended 2% per year,acute urinary retention,recurrent hematuria,urinary infection,bilateral hydronephrosis,or finally undergone surgery were considered to have disease progression.Using the Grade 1 IPP group as a reference,the odds ratio for clinical progression of Grade 2 and Grade 3 IPP were calculated by using multivariate analysis.Results A total of 537 patients with mean follow-up time of 29 months were available for analysis.191 patients were found to have clinical progression.Odds ratio for progression of a Grade 2 IPP was 7.4 and that of a Grade 3 IPP was 15.1.Conclusion A higher IPP grade is associated with a higher risk of clinical progression in BPH.IPP is a useful non-invasive predictor for clinical progression in BPH.
What problem does this paper attempt to address?